Semaglutide 2mg – Ozempic – Fat-Burning Peptide
Semaglutide 2mg – Ozempic
Composition: Semaglutide 2 mg
Category: Peptide
Indication: Body weight control and appetite modulation
Dosage form: Vial containing 2 mg of lyophilized powder with a separate vial of 1 ml of water for injections, intended for reconstitution
Route of administration: Subcutaneous injection
- Shipping (if the product is in stock): 3 business days for processing and 5 to 20 business days for shipping
- Processing and shipping costs: €27 throughout Italy
What is Ozempic (Semaglutide)?
Ozempic is a drug based on Semaglutide , a peptide-based GLP-1 receptor agonist, developed for the treatment of type 2 diabetes and now also widely used for weight management and metabolic health.
Semaglutide works by mimicking the gut hormone GLP-1, which regulates satiety and appetite , and blood sugar control. Thanks to this mechanism, Ozempic effectively reduces hunger and promotes gradual and sustainable weight loss.
Main effects of Ozempic (Semaglutide)
🍽 Appetite control
Semaglutide reduces central hunger signals and slows gastric emptying, prolonging the feeling of fullness after meals.
🩸 Blood Sugar Regulation
Ozempic stimulates insulin secretion in response to meals and reduces the release of glucagon, helping to stabilize blood sugar levels, especially in cases of insulin resistance.
⚖️ Weight Loss
By reducing calorie intake and improving appetite control, Semaglutide promotes fat loss without resorting to extreme diets.
🫀 Metabolic and cardiovascular support
Ozempic use is often associated with improvements in blood pressure, lipid profile, and inflammatory markers, reducing overall metabolic risk.
How to Take Ozempic (Semaglutide)
Semaglutide is supplied in a 2 mg vial of lyophilized powder and must be reconstituted with water for injections before use.
It is administered via subcutaneous injection once a week , always on the same day.
Recommended dosage schedule
-
Weeks 1–4: 0.25 mg
-
Weeks 5–8: 0.5 mg
-
Weeks 9–12: 1.0 mg
-
Week 13+: Up to 2.0 mg (only if needed and well tolerated)
There is no need to increase the dose if the current dose is already effective and well tolerated.
Precautions and side effects
Possible side effects:
-
Nausea (more common in the first few weeks)
-
Reduction in appetite
-
Bloating or mild digestive discomfort
-
Headache or fatigue
Main contraindications:
-
Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
-
Pregnancy and breastfeeding
-
Concomitant use with other GLP-1 agonists (e.g., tirzepatide, retatrutide)
Conservation
-
Store in the refrigerator at 2–8°C
-
Do not freeze
-
Keep away from light
-
Once reconstituted, use within approximately 30 days.















